Nonlinear association between metabolic score for insulin resistance and incident cardiovascular disease in postmenopausal women: a threshold analysis from the CHARLS cohort
This study of Chinese postmenopausal women from the CHARLS cohort reveals a nonlinear, threshold-dependent relationship between the metabolic score for insulin resistance (METS-IR) and incident cardiovascular disease, characterized by a protective effect below an inflection point of 24.83 and an increased risk above it.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, doctors have known that when the body struggles to use sugar for energy, the heart pays the price. This struggle, known as insulin resistance, is a silent driver of heart disease, clogging arteries and straining the heart muscle long before a patient feels sick. It is especially dangerous for women after menopause. When estrogen levels drop, the body's ability to manage sugar and fat changes, often pushing women toward this dangerous state more quickly than before. To catch this problem early, researchers look for clues in routine blood tests. One such clue is a calculation called the metabolic score for insulin resistance. It is a number derived from common measurements: blood sugar, triglycerides (a type of fat in the blood), good cholesterol, and body mass index. For years, the medical community assumed that the higher this number went, the higher the risk of heart disease would climb in a straight, predictable line. But biology is rarely a straight line, and a new study suggests that for women after menopause, the story is far more complex.
A team of researchers turned to a massive, long-running survey of Chinese adults to test this assumption. They focused specifically on nearly 3,000 women who had passed menopause and were free of heart disease at the start of the study. Over the course of seven years, these women were followed to see who developed heart disease or stroke. The researchers calculated the metabolic score for insulin resistance for each woman at the beginning and watched how the numbers played out over time. They did not just look for a simple upward trend; they used advanced statistical tools to search for a turning point, a specific moment where the relationship between the score and heart risk might change direction or intensity.
What they found overturned the simple idea of a straight line. The data revealed a distinct threshold, a critical tipping point at a score of 24.83. Below this number, the story was surprisingly different from what doctors expected. In this lower range, as the score went up, the risk of developing heart disease actually went down slightly. It was as if the body was still managing its sugar and fat well enough that small increases in the score did not signal danger. However, once the score crossed that specific threshold of 24.83, the rules changed completely. Above this point, the relationship flipped into a steep climb. For every single unit the score increased beyond 24.83, the risk of a new heart event rose by two percent. This was not a gradual, gentle slope; it was a sharp inflection where the protective buffer vanished and the danger began to mount rapidly.
The study included women with a wide variety of backgrounds, most living in rural areas with lower levels of formal education, which makes the findings broadly relevant to the general population. The researchers were careful to account for other factors that could skew the results, such as age, whether a woman lived in a city or the countryside, her education level, and her marital status. Even after adjusting for these variables, the threshold effect remained clear and statistically significant. The data showed that the average woman in the study had a score of 35.73, meaning that a large portion of the group was already living above the danger line at the start of the research. This suggests that many postmenopausal women who might currently be considered only moderately at risk are actually sitting in a zone where their heart risk is accelerating.
This discovery matters because it changes how we might view risk in the clinic. For years, doctors have treated insulin resistance as a problem that gets worse the higher the number goes, with no safe zone or specific point where the danger truly begins. This study suggests that there is a specific point where the body's defenses break down. Below 24.83, the body may still be compensating effectively, but once a woman crosses that line, the metabolic machinery begins to fail in a way that directly harms the heart. The researchers noted that this score is easy to calculate using standard blood tests and a height and weight measurement, tools available in almost any doctor's office. They propose that identifying women who have crossed this specific threshold could help doctors decide who needs more aggressive lifestyle changes or medication to protect their hearts.
The study does not claim to have solved the mystery of heart disease, nor does it suggest that this single number is a perfect crystal ball. The researchers acknowledged that the data relied on women reporting their own medical histories, which can sometimes be imperfect, and that they only measured the score once at the beginning of the study. They also noted that the specific number of 24.83 needs to be tested in other groups of people to ensure it holds true everywhere. However, the evidence from this large group of Chinese women is strong enough to challenge the old, linear way of thinking. It paints a picture of a biological system that holds steady for a while, then suddenly shifts into high gear for danger. For women navigating the years after menopause, understanding where they stand relative to this invisible line could be the difference between staying healthy and facing a preventable heart event.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.